These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 25628060)

  • 21. [Bevacizumab combined with chemotherapy in the treatment of solid tumors: the novelty from ASCO 2005].
    Longo F; Mansueto G
    Tumori; 2005; 91(4):suppl 1-7. PubMed ID: 16277111
    [No Abstract]   [Full Text] [Related]  

  • 22. Adjuvant Therapy After Resection of Metastatic Colorectal Cancer: Scant Evidence of a Curative Benefit.
    Marshall JL
    Oncology (Williston Park); 2016 Jan; 30(1):50, 52-3. PubMed ID: 26791845
    [No Abstract]   [Full Text] [Related]  

  • 23. [Are there indications for adjuvant chemotherapy after excision of colorectal cancer?].
    Gérard A
    Pathol Biol (Paris); 1989 Nov; 37(9):990. PubMed ID: 2691974
    [No Abstract]   [Full Text] [Related]  

  • 24. Retrospective cohort study on the safety and efficacy of bevacizumab with chemotherapy for metastatic colorectal cancer patients: the HGCSG0801 study.
    Sogabe S; Komatsu Y; Yuki S; Kusumi T; Hatanaka K; Nakamura M; Kato T; Miyagishima T; Hosokawa A; Iwanaga I; Sakata Y; Asaka M
    Jpn J Clin Oncol; 2011 Apr; 41(4):490-7. PubMed ID: 21303790
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cetuximab in the treatment of colorectal cancer.
    Goldberg RM; Venook AP; Schilsky RL
    Clin Adv Hematol Oncol; 2004 Nov; 2(11):1-10; quiz 11-12. PubMed ID: 16170891
    [No Abstract]   [Full Text] [Related]  

  • 26. Metastatic colorectal cancer.
    Bouche O; Conroy T; Michel P; Penna C; Tournigand C
    Gastroenterol Clin Biol; 2006 Sep; 30 Spec No 2():2S30-2S42. PubMed ID: 17151561
    [No Abstract]   [Full Text] [Related]  

  • 27. Chemotherapy for colorectal carcinoma: observations regarding recent clinical trials using biochemical modulation.
    Wadler S; Schwartz EL
    J Clin Oncol; 1995 Oct; 13(10):2676-7. PubMed ID: 7595721
    [No Abstract]   [Full Text] [Related]  

  • 28. Survival benefit from up-front fluorouracil, leucovorin, and irinotecan/cetuximab in metastatic colorectal cancer: is it just a now-or-never result?
    Rother MJ
    J Clin Oncol; 2011 Nov; 29(31):4207; author reply 4207-8. PubMed ID: 21931017
    [No Abstract]   [Full Text] [Related]  

  • 29. Chronomodulated chemotherapy in advanced colorectal carcinoma.
    Price T; Karapetis C
    J Clin Oncol; 2002 Sep; 20(18):3937-8; author reply 3938-9. PubMed ID: 12228219
    [No Abstract]   [Full Text] [Related]  

  • 30. Improvements in fluorouracil chemotherapy?
    Einhorn LH
    J Clin Oncol; 1989 Oct; 7(10):1377-9. PubMed ID: 2674329
    [No Abstract]   [Full Text] [Related]  

  • 31. Time to tumor growth: a model end point and new metric system for oncology clinical trials.
    Maitland ML; Schwartz LH; Ratain MJ
    J Clin Oncol; 2013 Jun; 31(17):2070-2. PubMed ID: 23650409
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical trials referral resource. Current phase II and phase III clinical trials in the treatment of colorectal cancer.
    Mooney MM; Schoenfeldt M
    Oncology (Williston Park); 2004 Oct; 18(11):1396, 1401, 1404 passim. PubMed ID: 15609469
    [No Abstract]   [Full Text] [Related]  

  • 33. Current treatment benefits in advanced colorectal cancer.
    Scheithauer W
    Lancet Oncol; 2007 Oct; 8(10):857-9. PubMed ID: 17913652
    [No Abstract]   [Full Text] [Related]  

  • 34. New lessons from "old" chemotherapy in colorectal cancer.
    Grothey A; Sargent DJ
    J Clin Oncol; 2008 Oct; 26(28):4532-4. PubMed ID: 18824704
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical trials referral resource. Treatment of advanced colorectal cancer.
    Cheson BD
    Oncology (Williston Park); 1991 Apr; 5(4):61-2, 65-6, 68 passim. PubMed ID: 1831041
    [No Abstract]   [Full Text] [Related]  

  • 36. Highlights in metastatic colorectal cancer from the 2012 American Society Of Clinical Oncology Annual Meeting.
    Grothey A
    Clin Adv Hematol Oncol; 2012 Jul; 10(7 Suppl 9):1-24. PubMed ID: 22895157
    [No Abstract]   [Full Text] [Related]  

  • 37. Maintenance therapy in metastatic colorectal cancer.
    Marshall JL
    Clin Adv Hematol Oncol; 2014 Jun; 12(6):388-90. PubMed ID: 25003569
    [No Abstract]   [Full Text] [Related]  

  • 38. [New drugs for colorectal cancer: UFT].
    Frontini L
    Tumori; 2001; 87(1 Suppl 1):S57-8. PubMed ID: 11300028
    [No Abstract]   [Full Text] [Related]  

  • 39. Hypomagnesemia is a reliable predictor for efficacy of anti-EGFR monoclonal antibody used in combination with first-line chemotherapy for metastatic colorectal cancer.
    Fujii H; Iihara H; Suzuki A; Kobayashi R; Matsuhashi N; Takahashi T; Yoshida K; Itoh Y
    Cancer Chemother Pharmacol; 2016 Jun; 77(6):1209-15. PubMed ID: 27106835
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adjuvant chemotherapy for colorectal cancer.
    Maughan TS
    Br J Cancer; 2001 Nov; 85(10):1422-4. PubMed ID: 11720422
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.